Intercepting Cancer When DNA Surveillance Fails

Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is trying to change that by training the immune system to spot and destroy cancer cells before tumors ever form. We spoke to Marina Udier, CEO of Nouscom, about the company’s experimental cancer vaccines, how they work, and the broader potential for the company’s off‑the‑shelf cancer therapies.

You can listen to Intercepting Cancer When DNA Surveillance Fails online on Radio and Podcast. Open the player on this page to stream the available audio.

Intercepting Cancer When DNA Surveillance Fails is an episode from The Bio Report by Levine Media Group.

This episode is 39:29 long.

This episode was published on Apr 8, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Bio Report when more episodes are available from the podcast feed.